Nizharadze N, Mamaladze M, Chipashvili N, Vadachkoria D
Tbilisi State Medical University, Dental clinic, Training and Research center "UniDent", Georgia.
Georgian Med News. 2011 Jan(190):15-23.
Local anesthesia forms the foundation of pain control techniques in clinical dentistry. Within the rich local anesthetic drugs available in dentistry for the prevention and management of pain 4% articaine solutions achieve highest level of anesthetic potency and lowest systemic toxicity in all clinical situations, prior to its superlative physicochemical characteristics and the pharmacological profile. These are - low lipid solubility, high plasma protein binding rate, fast metabolization, fast elimination half time; low blood level. Articaine inactivates in both ways: in the liver and the blood serum. It has good spreading through tissues. Thus, articaine seems to be the local anesthetic of first choice in tissues with suppurative inflammation, for adults, children (over 4), elderly, pregnant women, breastfeeding women, patients suffering from hepatic disorders and renal function impairment. In Articaine solutions (1: 200,000) epinephrine is in low concentration, thus in patients at high risk adverse responses are maximally decreased. In these patients articaine should be used with careful consideration of risk/benefit ratio. Articaine solutions must not be used in persons who are allergic or hypersensitive to sulphite, due to content of Sodium metabisulfite as vasoconstrictor's antioxidant in it. Incidence of serious adverse effects related to dental anesthesia with articaine is very low. Toxic reactions are usually due to an inadvertent intravascular injection or use of excessive dose. To avoid overdoses maximum recommendation dose (MRD) must not be exceeded and aspiration test always performed prior all LA injections. In these article we introduce new graphs providing a quick and effect way to determine maximum LA dose. If the overdose reactions develop, adherence to the basic step of emergency management with end to a successful outcome in virtually all cases.
局部麻醉是临床牙科疼痛控制技术的基础。在牙科用于预防和控制疼痛的丰富局部麻醉药物中,4%阿替卡因溶液在所有临床情况下都具有最高的麻醉效能和最低的全身毒性,这得益于其卓越的理化特性和药理学特征。这些特性包括:低脂溶性、高血浆蛋白结合率、快速代谢、快速消除半衰期;低血药浓度。阿替卡因通过肝脏和血清两种途径失活。它在组织中具有良好的扩散性。因此,对于患有化脓性炎症的组织、成人、儿童(4岁以上)、老年人、孕妇、哺乳期妇女、患有肝脏疾病和肾功能损害的患者,阿替卡因似乎是首选的局部麻醉剂。在阿替卡因溶液(1:200,000)中肾上腺素浓度较低,因此在高危患者中不良反应可最大程度降低。对于这些患者,使用阿替卡因时应仔细考虑风险/获益比。由于其中含有焦亚硫酸钠作为血管收缩剂的抗氧化剂,对亚硫酸盐过敏或超敏的人不得使用阿替卡因溶液。与使用阿替卡因进行牙科麻醉相关的严重不良反应发生率非常低。毒性反应通常是由于意外血管内注射或使用过量剂量所致。为避免用药过量,不得超过最大推荐剂量(MRD),并且在所有局部麻醉注射前都必须进行回抽试验。在本文中,我们介绍了新的图表,提供了一种快速有效的方法来确定最大局部麻醉剂量。如果发生用药过量反应,遵循基本的急救步骤几乎在所有情况下都能取得成功的结果。